Guo Rui Yinuo has been recognized by the Shaanxi Provincial Department of Science and Technology as a new-type R&D institution in Shaanxi Province.
Release time:
2024-07-10 18:31
Keywords:
2024 Year 07 Moon 08 On the day, Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. passed... Shaanxi Provincial Department of Science and Technology “ 2024 Annual Recognition of New R&D Institutions in Shaanxi Province. 
To enhance the industry’s independent innovation capabilities and promote the local transformation of scientific and technological achievements, the Provincial Department of Science and Technology is actively taking steps. The work of identifying new R&D institutions in Shaanxi Province is underway. These new R&D institutions in Shaanxi Province are a vital force in the construction of the Qin Chuangyuan innovation-driven platform. They aim to strengthen technological research and development, pilot-scale testing and maturation, technology transfer and commercialization, and enterprise incubation. By focusing on deepening the integration of industrial and innovation chains, they seek to enhance the overall effectiveness of Shaanxi’s innovation system and provide robust scientific and technological support for our province’s high-quality development.
The new R&D institutions in Shaanxi Province are registered and operated within Shaanxi Province. 1 Enterprises, institutions, or social service organizations (non-profit private entities) with more than one year of operational experience and independent legal status; possessing diversified investor structures and modern management systems, implementing efficient operational mechanisms such as market-oriented decision-making and technology transfer and commercialization processes; focusing on the planning and layout of our province’s leading and emerging industries, with primary functions including the commercialization of scientific and technological achievements, R&D in industrial technologies, incubation of science and technology enterprises, and promoting the integration of two key chains; relying primarily on contract research and technology services as their main revenue sources, and having a clearly defined business development direction.
Guo Rui, a promise kept. 2021 Year 07 The drug has been approved by the National Medical Products Administration. GLP (Certification for Good Laboratory Practice in Non-Clinical Drug Studies) fills a gap in our province. GLP The laboratory’s blank slate will establish a convenient, efficient, and reliable technical platform for new drug research and preclinical safety evaluation in Shaanxi Province’s pharmaceutical industry, playing a crucial role in further enhancing Shaanxi Province’s drug R&D capabilities, its independent innovation capacity in the pharmaceutical sector, and the quality of drug research. Guorui Yinuo has currently obtained approval from the Ministry of Agriculture and Rural Affairs of China for veterinary drugs. GLP 、 GCP Certification, accredited by the China National Accreditation Service for Conformity Assessment CNAS GLP Certificate.
Guorei Yinuo has obtained the designation of National High-Tech Enterprise. Qin Chuangyuan: Integration of Two Chains “Promoter,” Innovative Small and Medium-sized Enterprises of Shaanxi Province 、 Xi'an Engineering and Technology Research Center Xi'an's New R&D Institutions ” Determine 。
Guo Rui Yinuo’s building area reaches 6000 Square meters, Phase I investment 3000 Over several hundred thousand yuan, the facility is now equipped with a liquid chromatography-mass spectrometry system, a high-performance liquid chromatograph, a fully automatic chemiluminescence analyzer, an animal blood analyzer, an automated tissue dehydrator, a pathology diagnostic microscopy system, a microscale laboratory balance, an animal oral and nasal inhalation exposure system, and a UV-Vis spectrophotometer, among other instruments. 300 We have a comprehensive suite of instruments and equipment, and have established experimental platforms covering genetic toxicology, reproductive toxicology, analytical testing, and clinical pathology. Our company is dedicated to non-clinical safety evaluation of drugs, offering clients a one-stop service that includes personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, safety assessments, and analysis of clinical trial samples. We also provide services for safety evaluations of food, health supplements, cosmetics, and medical devices. In addition, we have set up platforms for the development of disease model animals and the breeding of laboratory animals. Our company boasts a stable, experienced, and highly qualified professional team, and has established systems that comply with U.S. standards. FDA 、 OECD And China NMPA Regulatory requirements GLP System.
Related News
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681